ATXA Therapeutics
PrivateLast Round
Crowdfunding
Jan 22, 2024
Est. Valuation
$37.46M
Total Funding Raised
$10.14M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
ATXA Therapeutics is a clinical-stage pharmaceutical company that develops novel, life-changing treatments for cardiopulmonary diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ATXA Therapeutics Comparables
Compare ATXA Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cereno Scientific | 78% | |
| Sumitomo Pharma Co., Ltd. | 71% | |
| Gossamer Bio | 71% | |
ATXA Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Crowdfunding | Jan 22, 2024 | ||||
| Grant | Oct 21, 2022 | ||||
| Grant | Oct 31, 2018 | ||||
| Seed | Apr 1, 2018 |
Key People
Founding team and executive leadership
ATXA Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| European Commission | Grant |
| Spark Venture Funding | Crowdfunding |
| Enterprise Ireland | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 20, 2026
Monthly visitors increased 35% MoM.
- Jan 5, 2026
Monthly visitors increased 51% MoM.
ATXA Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ATXA Therapeutics's valuation, stock price, and market status.